Air Products & Chemicals, Inc.: Form 10-Q for the period ended Jun 30, 2009
Filed with the SEC on Jul 24, 2009 and accepted by EDGAR at Jul 24, 2009, 15:15 ET.
Management's discussion and analysis
As filed, 51,339 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(Millions of dollars, except for share data)
The disclosures in this quarterly report are complementary to those made in the Company’s 2008 annual report on Form 10-K. An analysis of results for the third quarter and first nine months of 2009, including an update to the Company’s 2009 Outlook, is provided in the Management’s Discussion and Analysis to follow.
All comparisons in the discussion are to the corresponding prior year unless otherwise stated. All amounts presented are in accordance with U.S. generally accepted accounting principles, except as noted. All amounts are presented in millions of dollars, except for share data, unless otherwise indicated.
THIRD QUARTER 2009 VS. THIRD QUARTER 2008
THIRD QUARTER 2009 IN SUMMARY
- Due to the continuing slow economic recovery, the Company committed to additional actions associated with its global cost reduction plan which resulted in a charge to continuing operations of $124.0 ($84.2 after-tax, or $.39 per share). Additionally, the results included a charge of $32.1 ($21.0 after-tax, or $.10 per share) for a customer bankruptcy and asset actions, and a charge of $8.0 ($5.0 after-tax, or $.02 per share) for pension settlements.
- Sales of $1,976.2 declined 28%. Underlying business declined 11% from lower volumes primarily in the Electronics and Performance Materials and Merchant Gases segments and also in the Tonnage Gases segment. Additionally, lower energy and raw material cost pass-through to customers and unfavorable currency negatively impacted sales.
- Operating income of $143.8 declined $249.9 principally from lower volumes, the additional global cost reduction charge, and unfavorable currency impacts. In addition, operating income was lower as a result of the charge of $32.1 for the customer bankruptcy and asset actions and from the $8.0 pension settlement. The previous cost reduction actions favorably impacted operating income and resulted in lower operating and overhead costs.
- Income from continuing operations of $114.6 declined $180.4 and diluted earnings per share from continuing operations of $.54 declined $.81. A summary table of changes in diluted earnings per share is presented below.
- Loss from discontinued operations in the prior year included an after-tax charge of $237.0, or $1.09 per share, related to the impairment of the U.S. Healthcare assets.
- For a discussion of the challenges, risks, and opportunities on which management is focused, refer to the update to the Company’s 2009 Outlook provided on page 37.
24
Changes in Diluted Earnings per Share
| Diluted Earnings per Share Net Income | Three Months Ended 30 June 2009 $.53 | 2008 $.32 | Increase (Decrease) $.21 |
|---|---|---|---|
| Discontinued Operations | (.01) | (1.03) | 1.02 |
| Continuing Operations | $.54 | $1.35 | $(.81) |
| Operating Income (after-tax) | |||
| Underlying business | |||
| Volume | (.47) | ||
| Price/energy and raw materials | .06 | ||
| Costs | .20 | ||
| Currency | (.09) | ||
| Global cost reduction plan | (.39) | ||
| Customer bankruptcy and asset actions | (.10) | ||
| Pension settlement | (.02) | ||
| Operating Income | (.81) | ||
| Other (after-tax) | |||
| Equity affiliates’ income | (.06) | ||
| Interest expense | .04 | ||
| Minority interest | .01 | ||
| Income tax rate | (.01) | ||
| Average shares outstanding | .02 | ||
| Other | .00 | ||
| Total Change in Diluted Earnings per Share from Continuing Operations | $(.81) |
RESULTS OF OPERATIONS
Discussion of Consolidated Results
| Three Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $1,976.2 | $2,749.7 | (28)% |
| Operating income | 143.8 | 393.7 | (63)% |
| Equity affiliates’ income | 28.5 | 46.5 | (39)% |
Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (11)% |
| Price | — |
| Currency | (6)% |
| Energy/raw material cost pass-through | (11)% |
| Total Consolidated Change | (28)% |
Sales of $1,976.2 decreased 28%, or $773.5. Underlying business declined 11% from lower volumes primarily in the Electronics and Performance Materials, Merchant Gases, and the Tonnage Gases segments. Currency unfavorably impacted sales by 6%, due primarily to the strengthening of the U.S. dollar against key European and Asian currencies. Lower energy and raw material contractual cost pass-through to customers reduced sales by 11%.
Operating Income
Operating income of $143.8 decreased 63%, or $249.9.
- The global cost reduction plan charge reduced operating income by $124.0.
- The write-off of certain receivables, due to a customer bankruptcy, and asset actions reduced operating income by $32.1.
- Pension settlement charges reduced operating income $8.0.
- Underlying business declined $60, primarily from lower volumes. Volume declines were partially offset by higher prices in Merchant Gases and favorable cost performance.
- Unfavorable currency impacts reduced operating income by $26.
Equity Affiliates’ Income
Income from equity affiliates of $28.5 decreased 39%, or $18.0. Several factors contributed to this unfavorable variance. Prior year results included favorable adjustments, which accounts for approximately one-third of the decline. Other factors included unfavorable currency impacts and lower volumes, particularly in Italy.
Selling and Administrative Expense (S&A)
S&A expense of $232.3 decreased 18%, or $52.1. S&A, as a percent of sales, increased to 11.8% from 10.3%. Favorable currency impacts, primarily the strengthening of the U.S. dollar against the Euro and Pound Sterling, decreased S&A by 7%. Underlying costs decreased 12% primarily due to improved productivity and lower discretionary spending, partially offset by inflation and higher bad debt expense.
Research and Development (R&D)
R&D expense of $24.1 decreased 27%, or $9.0, primarily due to the impact of cost reduction actions and a reimbursement of R&D costs in the energy business. R&D, as a percent of sales, remained unchanged at 1.2%.
Global Cost Reduction Plan
During the third quarter ended 30 June 2009, due to the continuing slow economic recovery, the Company committed to additional actions associated with its global cost reduction plan which resulted in a charge to continuing operations of $124.0 ($84.2 after-tax, or $.39 per share). This charge included $90.0 for severance and other benefits, including pension-related costs, associated with the elimination of approximately 1,150 positions of its global workforce. The reductions are targeted at continued cost reduction and productivity efforts, including the closure of certain manufacturing facilities. An impairment charge of $34.0 was recorded to write-down certain assets held for sale to net realizable value.
The charge for the global cost reduction plan has been excluded from segment operating profit. The charge was related to the businesses at the segment level as follows: $43.5 in Merchant Gases, $3.1 in Tonnage Gases, $20.6 in Electronics and Performance Materials, and $56.8 in Equipment and Energy.
The planned actions associated with the third quarter charge are expected to be substantially completed by the end of the third quarter of fiscal year 2010. Cost savings of approximately $30 are expected in 2010. Beyond 2010, the Company expects the actions associated with the third quarter charge to provide annualized savings of approximately $50, of which the majority is related to personnel costs. These annual cost savings do not reflect approximately $20 of project execution costs which are capitalized into projects. These savings will be reflected in lower future project costs.
Refer to Note 3 to the Consolidated Financial Statements for additional details on the global cost reduction plan.
Customer Bankruptcy and Asset Actions
As a result of events which occurred during the third quarter of 2009, the Company recognized a $22.2 charge primarily for the write-off of certain receivables due to a customer bankruptcy. This customer, who principally receives product from the Tonnage Gases segment, began operating under Chapter 11 bankruptcy protection on 6 January 2009. Sales and operating income associated with this customer are not material to the Tonnage Gases segment’s results. At 30 June 2009, the Company had remaining outstanding receivables with the customer of $16.4. At the present time, the Company does not expect to recognize additional charges related to this customer.
Additionally, the Company recorded a charge of $9.9 for other asset actions which consisted of the closure of certain manufacturing facilities. This charge was reflected in cost of sales on the consolidated income statement. The customer bankruptcy charge combined with this asset write-down resulted in a total charge of $32.1 ($21.0 after-tax, or $.10 per share).
Pension Settlement
The Company’s supplemental pension plan provides for a lump sum benefit payment option at the time of retirement, or for corporate officers six months after the participant’s retirement date. The Company recognizes pension settlements when payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the fiscal year. A settlement loss is recognized when the pension obligation is settled. Based on the timing of when cash payments were made, the Company recognized an $8.0 ($5.0 after-tax, or $.02 per share) charge in the third quarter of 2009. An additional $2 to $3 for settlement losses is expected to be recognized in the fourth quarter of 2009. For the three months ended 30 June 2008, the Company recognized $1.0 of settlement charges.
Other Income, Net
Items recorded to other income arise from transactions and events not directly related to the principal income earning activities of the Company.
Other income of $5.7 increased $2.1, primarily due to favorable foreign exchange. Otherwise, no individual items were significant in comparison to the prior year.
Interest Expense
| Three Months Ended 30 June 2009 | 2008 | |
|---|---|---|
| Interest incurred | $33.1 | $44.2 |
| Less: interest capitalized | 5.6 | 4.7 |
| Interest expense | $27.5 | $39.5 |
Interest incurred decreased $11.1, primarily due to lower average interest rates on variable-rate debt. The change in capitalized interest is driven by an increase in project spending which qualified for capitalization.
Effective Tax Rate
The effective tax rate equals the income tax provision divided by income from continuing operations before taxes less minority interest. The effective tax rate was 18.1% and 25.0% in the third quarter of 2009 and 2008, respectively. The effective tax rate declined as tax credits had a higher relative impact due to lower book taxable income.
Discontinued Operations
The U.S. Healthcare business, Polymer Emulsions business, and the High Purity Process Chemicals (HPPC) business have been accounted for as discontinued operations. The results of operations of these businesses have been removed from the results of continuing operations for all periods presented. Refer to Note 4 to the Consolidated Financial Statements for additional information.
U.S. Healthcare
During the third quarter of 2009, the Company sold more than half of its remaining U.S. Healthcare business to OptionCare Enterprises, Inc., a subsidiary of Walgreen Co., and Landauer-Metropolitan, Inc. (LMI) for cash proceeds of $38.1. The Company recognized an after-tax gain of $.3 resulting from these sales combined with adjustments to the net realizable value of the remaining businesses.
For the third quarter of 2008, the Company performed an impairment analysis and recorded a charge of $314.8 ($237.0 after-tax, or $1.09 per share). The impairment principally reduced the carrying amount of the U.S. Healthcare reporting unit goodwill and intangible assets to zero.
The U.S. Healthcare business generated sales of $25.2 and loss from operations, net of tax, of $(2.1) in the third quarter of 2009. Sales in the third quarter of 2008 were $58.3 and loss from operations was $(244.2), which included the impairment charge of $237.0.
Polymer Emulsions
On 30 June 2008, the Company sold its Elkton, Md. and Piedmont, S.C. production facilities and the related North American atmospheric emulsions and global pressure sensitive adhesives businesses to Ashland Inc. The Company recorded a gain of $30.5 ($18.5 after-tax) in connection with the sale, which included the recording of a retained environmental obligation associated with the Piedmont site. The sale of the Elkton and Piedmont facilities completed the disposal of the Company’s Polymer Emulsions business. In the third quarter of 2008, the Polymer Emulsions business generated sales of $31.4 and income from operations, net of tax, of $1.1.
Net Income
Net income was $113.2 compared to $70.1. Diluted earnings per share was $.53 compared to $.32. A summary table of changes in earnings per share is presented on page 25.
Segment Analysis
Merchant Gases
| Three Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $882.6 | $1,087.3 | (19)% |
| Operating income | 168.8 | 204.3 | (17)% |
| Equity affiliates’ income | 24.9 | 44.0 | (43)% |
Merchant Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (11)% |
| Price | 2% |
| Currency | (10)% |
| Total Merchant Gases Change | (19)% |
Sales of $882.6 decreased 19%, or $204.7. Underlying business declined 9%, with volumes down 11% and pricing up 2%. Volumes were weak across manufacturing end markets globally. Sales decreased 10% from unfavorable currency impacts, driven primarily by the strengthening of the U.S. dollar against key European and Asian currencies.
In North America, sales decreased 16% driven by a slow manufacturing climate. Volumes declined 19% and were impacted by lower argon with weak sales to distributors. Higher pricing of 3% partially offset the decline in volumes. In Europe, sales decreased 21% primarily due to unfavorable currency impacts of 16%. Underlying sales declined 5% with volumes down 8% and pricing adding 3%. Volumes were impacted by the weak manufacturing environment, partially offset by stronger healthcare sales. In Asia, sales declined by 16%. Underlying sales were lower by 9% with volumes declining 10% and pricing adding 1%. Currency unfavorably impacted sales by 7%.
Merchant Gases Operating Income
Operating income of $168.8 decreased 17%, or $35.5. Volume declines of $73 and unfavorable currency impacts of $21 reduced operating income. These declines were partially offset by higher pricing net of variable costs of $28 and improved cost performance of $31.
Merchant Gases Equity Affiliates’ Income
Merchant Gases equity affiliates’ income of $24.9 decreased 43%, or $19.1. Lower volumes, particularly in Italy, unfavorable currency, and a prior year favorable adjustment were the major factors for this decline.
Tonnage Gases
| Three Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $565.0 | $975.8 | (42)% |
| Operating income | 87.6 | 125.5 | (30)% |
Tonnage Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (6)% |
| Currency | (4)% |
| Energy/raw material cost pass-through | (32)% |
| Total Tonnage Gases Change | (42)% |
Sales of $565.0 decreased 42%, or $410.8. Lower energy and raw material contractual cost pass-through to customers reduced sales 32%. Refinery hydrogen volumes increased modestly, but volumes overall declined 6%. Tonnage volumes for steel and chemical customers declined due to lower operating rates. Also, a significant polyurethane intermediates customer was down for most of the quarter adding to the decline. Currency further reduced sales 4%.
Tonnage Gases Operating Income
Operating income of $87.6 decreased 30%, or $37.9. Underlying business declined $33 on lower volumes and reduced operating efficiencies compared to a strong prior year. Operating income further declined $5 due to unfavorable currency.
Electronics and Performance Materials
| Three Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $409.2 | $579.7 | (29)% |
| Operating income | 39.0 | 70.4 | (45)% |
Electronics and Performance Materials Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (24)% |
| Price | (2)% |
| Currency | (3)% |
| Total Electronics and Performance Materials Change | (29)% |
Sales of $409.2 decreased 29%, or $170.5. Underlying business declined 26% and currency reduced sales 3%. Electronics sales decreased 35%, with underlying business down 32% due to the significant downturn in semiconductor manufacturing. Currency negatively impacted Electronics sales by 3%. Performance Materials sales declined by 20% mainly due to lower volumes reflecting weakened demand across end markets.
Electronics and Performance Materials Operating Income
Operating income of $39.0 decreased 45%, or $31.4, primarily due to lower volumes. Costs were significantly reduced and partially offset this decline.
Equipment and Energy
| Three Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $119.4 | $106.9 | 12% |
| Operating income | 13.1 | 4.0 | 228% |
Equipment and Energy Sales and Operating Income
Sales of $119.4 increased 12%, or $12.5, due to increased large air separation unit (ASU) activity. Operating income of $13.1 increased $9.1, primarily due to improved cost performance.
The sales backlog for the Equipment business at 30 June 2009 was $253, compared to $399 at 30 September 2008.
Other
Other operating income (loss) includes expense and income that cannot be directly associated with the business segments, including foreign exchange gains and losses and interest income. Also included are LIFO inventory adjustments, as the business segments use FIFO and the LIFO pool is kept at corporate.
Other operating loss was $(.6) compared to a loss of $(9.5) primarily due to unfavorable foreign exchange in the prior year. No other individual items were significant in comparison to the prior year.
FIRST NINE MONTHS 2009 VS. FIRST NINE MONTHS 2008
FIRST NINE MONTHS 2009 IN SUMMARY
- In response to the weak economic conditions around the world, the Company implemented a global cost reduction plan designed to lower its cost structure and better align its businesses. Results from continuing operations included a total charge of $298.2 ($200.3 after-tax, or $.94 per share) for this plan.
- Sales of $6,126.9 declined 20%. Underlying business declined 8% principally from lower volumes in the Electronics and Performance Materials segment and also in the Merchant Gases and the Tonnage Gases segments. Additionally, lower energy and raw material cost pass-through to customers and unfavorable currency negatively impacted sales.
- Operating income of $518.3 declined $604.4 principally from lower volumes, the global cost reduction charges, and unfavorable currency impacts. Operating income also declined from a charge of $32.1 for a customer bankruptcy and asset actions, and from an $8.0 pension settlement. Improved pricing in the Merchant Gases segment and lower costs, as a result of the implementation of the reduction plan earlier in the year, partially offset the decline. Prior year results included a pension settlement charge of $28.7.
- Income from continuing operations was $393.9 as compared to $817.1. Diluted earnings per share from continuing operations was $1.85 as compared to $3.72. A summary table of changes in diluted earnings per share is presented below.
- Loss from discontinued operations was $(6.5) as compared to $(169.0). In 2009, the Company recorded an impairment charge of $48.7 ($30.9 after-tax, or $.15 per share), reflecting a revision in the estimated net realizable value of the U.S. Healthcare business. Also, the Company recognized tax benefits of $25.5 ($.12 per share) related to previously recognized impairment charges associated with this business. In 2008, the Company recorded a charge of $314.8 ($237.0 after-tax, or $1.09 per share) for the impairment of the U.S. Healthcare assets.
- The Company increased the quarterly dividend from $.44 to $.45 per share. This represents the 27th consecutive year that the Company has increased its dividend payment.
- For a discussion of the challenges, risks, and opportunities on which management is focused, refer to the update to the Company’s 2009 Outlook provided on page 37.
31
Changes in Diluted Earnings per Share
| Diluted Earnings per Share | Nine Months Ended 30 June 2009 | 2008 | Increase (Decrease) |
|---|---|---|---|
| Net Income | $1.82 | $2.95 | $(1.13) |
| Discontinued Operations | (.03) | (.77) | .74 |
| Continuing Operations | $1.85 | $3.72 | $(1.87) |
| Operating Income (after-tax) | |||
| Underlying business | |||
| Volume | (1.24) | ||
| Price/energy and raw materials | .25 | ||
| Costs | .34 | ||
| Currency | (.33) | ||
| Global cost reduction plan | (.94) | ||
| Customer bankruptcy and asset actions | (.10) | ||
| Pension settlement | .06 | ||
| Operating Income | (1.96) | ||
| Other (after-tax) | |||
| Equity affiliates’ income | (.12) | ||
| Interest expense | .08 | ||
| Income tax rate | .02 | ||
| Minority interest | .02 | ||
| Average shares outstanding | .09 | ||
| Other | .09 | ||
| Total Change in Diluted Earnings per Share from Continuing Operations | $(1.87) |
RESULTS OF OPERATIONS
Discussion of Consolidated Results
| Nine Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $6,126.9 | $7,699.8 | (20)% |
| Operating income | 518.3 | 1,122.7 | (54)% |
| Equity affiliates’ income | 80.0 | 114.2 | (30)% |
Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (10)% |
| Price | 2% |
| Currency | (6)% |
| Energy/raw material cost pass-through | (6)% |
| Total Consolidated Change | (20)% |
32
Sales of $6,126.9 decreased 20%, or $1,572.9. Underlying business declined 8%, due to lower volumes primarily in the Electronics and Performance Materials segment and also in the Merchant Gases and Tonnage Gases segments. Improved pricing in the Merchant Gases segment partially offset this decline. Currency unfavorably impacted sales by 6%, due primarily to the strengthening of the U.S. dollar against key European and Asian currencies. Lower energy and raw material contractual cost pass-through to customers reduced sales by 6%.
Operating Income
Operating income of $518.3 decreased 54%, or $604.4.
- The global cost reduction plan charges reduced operating income by $298.2.
- Underlying business declined $195, primarily from lower volumes in the Electronics and Performance Materials, Merchant Gases, and Tonnage Gases segments. The volume declines were partially offset by higher prices in the Merchant Gases segment and favorable cost performance.
- Unfavorable currency impacts lowered operating income by $98, reflecting the strengthening of the U.S. dollar against key European and Asian currencies.
- The write-off of certain receivables due to a customer bankruptcy and asset actions reduced operating income by $32.1.
- In 2009, an $8.0 pension settlement charge was recognized. Prior year results included a pension settlement charge of $28.7.
Equity Affiliates’ Income
Income from equity affiliates of $80.0 declined 30%, or $34.2. The decline is a result of lower income from equity affiliates within the Merchant Gases segment due to lower overall volumes and unfavorable currency. Additionally, prior year results included favorable adjustments made to certain affiliates in Asia and a fine reversal.
Selling and Administrative Expense (S&A)
S&A expense of $709.9 decreased 13%, or $105.1. S&A as a percent of sales, increased to 11.6% from 10.6%. Favorable currency impacts, primarily the strengthening of the U.S. dollar against the Euro and Pound Sterling, decreased S&A by 7%. Underlying costs decreased 7% primarily due to improved productivity, lower incentive compensation costs, and lower discretionary spending, partially offset by inflation and higher bad debt expense.
Research and Development (R&D)
R&D expense of $86.9 decreased 11%, or $10.8 due to the impact of cost reduction actions and a reimbursement of R&D costs in the energy business. R&D increased as a percent of sales to 1.4% from 1.3%.
Global Cost Reduction Plan
During the first quarter of 2009, the Company announced a global cost reduction plan designed to lower its cost structure and better align its businesses, and recorded a charge of $174.2 ($116.1 after-tax, or $.55 per share). In the third quarter of 2009, due to the continuing slow economic recovery, the Company committed to additional actions as part of its global cost reduction plan and recorded an additional charge of $124.0 ($84.2 after-tax, or $.39 per share). For the nine months ended 30 June 2009, the Company recorded charges for its global cost reduction plan totaling $298.2 ($200.3 after-tax, or $.94 per share).
The charges for the global cost reduction plan have been excluded from segment operating profit. The charges were related to the businesses at the segment level as follows: $134.7 in Merchant Gases, $14.2 in Tonnage Gases, $89.5 in Electronics and Performance Materials, and $59.8 in Equipment and Energy.
The planned actions associated with the first and third quarter 2009 charges are expected to be substantially completed by the end of the first and third quarter of fiscal year 2010, respectively. Cost savings of $50 are expected for 2009 and $155 in 2010. Beyond 2010, the Company expects the 2009 global cost reduction plan to provide annualized savings of approximately $180, of which the majority is related to personnel costs. These annual cost savings do not reflect approximately $20 of project execution costs which are capitalized into projects. These savings will be reflected in lower future project costs.
Refer to Note 3 to the Consolidated Financial Statements for additional details on the global cost reduction plan.
Customer Bankruptcy and Asset Actions
The Company recognized charges totaling $32.1 ($21.0 after-tax, or $.10 per share) related to a customer bankruptcy and asset actions for the closure of certain manufacturing facilities. Refer to Note 14 to the Consolidated Financial Statements for additional details on these charges.
Pension Settlement
The Company recognized an $8.0 ($5.0 after-tax, or $.02 per share) charge in the third quarter of 2009 for the settlement of pension plan liabilities. The Company recorded settlement losses of $28.7 ($17.9 after-tax, or $.08 per share) in 2008. An additional $2 to $3 for settlement losses is expected to be recognized in the fourth quarter of 2009. See Note 11 to the Consolidated Financial Statements for additional information.
Other Income, Net
Items recorded to other income arise from transactions and events not directly related to the principal income earning activities of the Company.
Other income of $13.7 declined 55%, or $16.9. This decline is due to losses from asset sales in the current year and unfavorable foreign exchange. No other individual items were significant in comparison to the prior year.
Interest Expense
| Nine Months Ended 30 June 2009 | 2008 | |
|---|---|---|
| Interest incurred | $109.8 | $136.7 |
| Less: interest capitalized | 15.8 | 17.5 |
| Interest expense | $94.0 | $119.2 |
Interest incurred decreased $26.9, primarily due to lower average interest rates on variable-rate debt. The change in capitalized interest is driven by a decrease in project spending which qualified for capitalization.
Effective Tax Rate
The effective tax rate equals the income tax provision divided by income from continuing operations before taxes less minority interest. The effective tax rate was 20.1% and 25.7% in 2009 and 2008, respectively. The effective tax rate declined due to higher relative tax credits based on lower income before taxes.
Discontinued Operations
The U.S. Healthcare business, Polymer Emulsions business, and the High Purity Process Chemicals (HPPC) business have been accounted for as discontinued operations. The results of operations of these businesses have been removed from the results of continuing operations for all periods presented. Refer to Note 4 to the Consolidated Financial Statements for additional information.
U.S. Healthcare
In the first quarter of 2009, based on additional facts, the Company recorded an impairment charge of $48.7 ($30.9 after-tax, or $.15 per share) reflecting a revision in the estimated net realizable value of the U.S. Healthcare business. Also, a tax benefit of $8.8, or $.04 per share, was recorded to revise the estimated tax benefit related to previously recognized impairment charges.
As a result of events which occurred during the second quarter of 2009, which increased the Company’s ability to realize tax benefits associated with the impairment charges recorded in 2008, the Company recognized a one-time tax benefit of $16.7, or $.08 per share.
During the third quarter of 2009, the Company sold more than half of its remaining U.S. Healthcare business to OptionCare Enterprises, Inc., a subsidiary of Walgreen Co., and Landauer-Metropolitan, Inc. (LMI) for combined cash proceeds of $38.1. The Company recognized an after-tax gain of $.3 resulting from these sales combined with adjustments to the net realizable value of the remaining businesses.
For the third quarter of 2008, the Company performed an impairment analysis and recorded a charge of $314.8 ($237.0 after-tax, or $1.09 per share) for the impairment of the U.S. Healthcare assets. The impairment principally reduced the carrying amount of the U.S. Healthcare reporting unit goodwill and intangible assets to zero.
The U.S. Healthcare business generated sales of $117.3 and loss from operations, net of tax, of $(2.0) in the first nine months of 2009. Sales for the same period in 2008 were $187.1 and loss from operations was $(256.1), which included the impairment charge of $237.0.
Polymer Emulsions
On 31 January 2008, the Company completed the sale of its interest in its vinyl acetate ethylene polymers joint ventures to Wacker Chemie AG (Wacker), its long-time joint venture partner. The Company recognized a gain on the sale of $89.5 ($57.7 after-tax).
On 30 June 2008, the Company sold its Elkton, Md. and Piedmont, S.C. production facilities and the related North American atmospheric emulsions and global pressure sensitive adhesives businesses to Ashland Inc. The Company recorded a gain of $30.5 ($18.5 after-tax) in connection with the sale, which included the recording of a retained environmental obligation associated with the Piedmont site. The sale of the Elkton and Piedmont facilities completed the disposal of the Company’s Polymer Emulsions business. In the first nine months of 2008, the Polymer Emulsions business generated sales of $261.4 and income from operations, net of tax, of $11.2.
Net Income
Net income of $387.4 declined 40%, or $260.7. Diluted earnings per share was $1.82 compared to $2.95. A summary table of changes in earnings per share is presented on page 32.
Segment Analysis
Merchant Gases
| Nine Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $2,678.2 | $3,097.7 | (14)% |
| Operating income | 495.5 | 593.3 | (16)% |
| Equity affiliates’ income | 72.0 | 105.9 | (32)% |
Merchant Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (9)% |
| Price | 5% |
| Currency | (10)% |
| Total Merchant Gases Change | (14)% |
Sales of $2,678.2 decreased 14%, or $419.5. Sales decreased 10% from unfavorable currency effects, driven primarily by the strengthening of the U.S. dollar against key European and Asian currencies. Volumes were lower across most product lines and regions, consistent with weak manufacturing worldwide. Price increases have been effective in all regions, partially offsetting the decline in volume.
In North America, sales decreased 8% due to lower volumes of 13% as a result of the global manufacturing downturn. Pricing gains of 5% partially offset the decline. In Europe, sales decreased 17%. Currency unfavorably impacted sales by 15% and volumes were lower by 7% due to weak demand across most end markets and regions in Europe. Improved pricing of 5% partially offset the decline. In Asia, sales decreased 13%. Volumes declined by 9% from the overall manufacturing slowdown in Asia, particularly from sales to electronics and steel customers. Improved pricing of 4% partially offset the decline in volume. Currency unfavorably impacted sales by 8%.
Merchant Gases Operating Income
Operating income of $495.5 decreased 16%, or $97.8. The decline was due to reduced volumes of $157 and unfavorable currency impacts of $64. These declines were partially offset by improved pricing, net of variable costs, of $80, and improved cost performance of $43.
Merchant Gases Equity Affiliates’ Income
Merchant Gases equity affiliates’ income of $72.0 decreased $33.9. The decline was a result of lower overall volumes and unfavorable currency. Additionally, prior year results included favorable adjustments made to certain affiliates in Asia and a fine reversal.
Tonnage Gases
| Nine Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $1,933.6 | $2,634.1 | (27)% |
| Operating income | 294.4 | 347.7 | (15)% |
Tonnage Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (6)% |
| Currency | (5)% |
| Energy/raw material cost pass-through | (16)% |
| Total Tonnage Gases Change | (27)% |
Sales of $1,933.6 decreased 27%, or $700.5. Lower energy and raw material contractual cost pass-through to customers reduced sales by 16%. Volumes were down 6% due to reduced demand from steel and chemical customers. Unfavorable currency reduced sales by 5%.
Tonnage Gases Operating Income
Operating income of $294.4 decreased 15%, or $53.3. Underlying business declined $33, primarily from lower volumes in the steel and chemical industries. Currency unfavorably impacted results $20.
Electronics and Performance Materials
| Nine Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $1,148.0 | $1,656.1 | (31)% |
| Operating income | 52.5 | 204.0 | (74)% |
Electronics and Performance Materials Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (28)% |
| Price | (1)% |
| Currency | (2)% |
| Total Electronics and Performance Materials Change | (31)% |
Sales of $1,148.0 decreased 31%, or $508.1, primarily from lower volumes. In Electronics, sales were down 37%, reflecting a significant global downturn in semiconductor and flat panel capacity utilization. In Performance Materials, sales were down 20% due to weaker demand across all end markets, partially offset by improved pricing. Volumes were impacted by weakness in coatings, autos, and housing end markets. Unfavorable currency added to the decline.
Electronics and Performance Materials Operating Income
Operating income of $52.5 decreased 74%, or $151.5, as result of lower volumes across the segment of $174, lower pricing of $28, and unfavorable currency of $5. Reduced costs of $55 partially offset this decline.
Equipment and Energy
| Nine Months Ended 30 June 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $367.1 | $311.9 | 18% |
| Operating income | 36.4 | 23.3 | 56% |
Equipment and Energy Sales and Operating Income
Sales of $367.1 increased 18%, or $55.2, due to higher large ASU activity. Operating income of $36.4 increased $13.1, due primarily to favorable cost performance, partially offset by lower liquefied natural gas (LNG) heat exchanger activity.
Other
Other operating income (loss) includes expense and income that cannot be directly associated with the business segments, including foreign exchange gains and losses and interest income. Also included are LIFO inventory adjustments, as the business segments use FIFO and the LIFO pool is kept at corporate.
The operating loss was $(22.2) compared to $(16.9), primarily due to unfavorable foreign exchange. No other individual items were significant in comparison to the prior year.
2009 OUTLOOK
The global economy deteriorated significantly during the first half of 2009. Due to the continuing slow economic recovery in the third quarter, the Company committed to additional actions and recognized a charge associated with its global cost reduction plan. Charges resulting from a customer bankruptcy and asset actions were also recognized. The Company anticipates an additional $20 to $30 of charges associated with the global cost reduction plan and asset actions to be incurred over the next several quarters. Continuing difficult economic conditions may continue to have negative effects on our business. While at the present time, the Company does not expect a material impact on results, the Company will continue to monitor economic conditions and the impacts to customers. The discussion below outlines the areas of challenge, risk, and opportunity on which management is focused.
For the remainder of the year, the Company expects Merchant Gases volumes to be in-line with the third quarter’s results with weak volumes in Europe due to continuing weak manufacturing demand during the summer holidays. Asia volumes are expected to continue to improve. North American volumes are expected to remain near third quarter levels resulting in continuing low capacity utilization. Maintaining the improved pricing that we have seen year to date in North America will be a challenge. In the Tonnage Gases segment, volumes should improve as capacity utilization rates increase in the steel and chemical businesses. Refinery hydrogen volumes should also improve modestly from current levels across most of the pipeline franchises due to higher demand and fewer customer outages. Also, higher polyurethane intermediates volumes are expected. In the Electronics and Performance Materials segment, the Company expects slightly higher volumes; however, this increase will be offset by ongoing restructuring costs. In Equipment and Energy, a decline in operating results is expected due to the ongoing restructuring costs. With the cost reduction actions that the Company is taking, favorable cost performance is expected.
Capital Expenditures
Capital expenditures for new plant and equipment are expected to be approximately equal to fiscal year 2008 spending.
SHARE-BASED COMPENSATION
Refer to Note 9 to the Consolidated Financial Statements for information on the Company’s share-based compensation programs. For additional information on the valuation and accounting for the various programs, refer to Note 15 to the Consolidated Financial Statements in the Company’s 2008 annual report on Form 10-K.
PENSION BENEFITS
Refer to Note 11 to the Consolidated Financial Statements for details on pension cost and cash contributions. For additional information on the Company’s pension benefits and associated accounting policies, refer to the Pension Benefits section of Management’s Discussion and Analysis and Note 18 to the Consolidated Financial Statements in the Company’s 2008 annual report on Form 10-K.
LIQUIDITY AND CAPITAL RESOURCES
Cash Flow
The narrative below refers to the Consolidated Statements of Cash Flows included on page 6.
Operating Activities
For the first nine months, net cash provided by operating activities decreased $272.3, or 24%. This decrease was primarily due to lower earnings of $260.7. Adjustments to income, primarily non-cash asset impairment charges and gains on the sale of discontinued operations, decreased cash from operating activities by $77.2. In 2009, impairment charges of $116.4 related to the global cost reduction plan and the discontinued U.S. Healthcare business. In 2008, U.S. Healthcare impairment charges totaling $314.8 were partially offset by gains of $119.5 on the sale of the HPPC and Polymer Emulsion businesses.
The net increase in cash provided by working capital (positive cash flow variance) of $65.6 primarily included:
- A $355.9 positive cash flow variance due to lower trade receivables as a result of reduced sales.
- A $292.5 negative cash flow variance due to a higher use of cash for payables and accrued liabilities. The negative variance was due principally to higher pension contributions and a decrease in accounts payables, customer advances, and other operating liabilities as a result of lower operating activity. The negative variances were partially offset by an increase in accrued liabilities resulting from the global cost reduction plan.
Investing Activities
Cash used for investing activities increased $268.2, due principally to lower proceeds from the sale of discontinued businesses and increased spending on plant and equipment, partially offset by changes to restricted cash. The current year included proceeds from the sale of certain U.S. Healthcare companies of $39.0, while the prior year included proceeds from the sale of the HPPC and Polymer Emulsions businesses of $419.5. Capital expenditures increased $135.0 due to higher spending on plant and equipment. The net change in restricted cash in 2009 was a source of cash of $82.2 versus a use of cash in the prior year of $135.6. In 2009, there was a net reduction in restricted cash, as project spending exceeded bond proceeds. The proceeds from the issuance of certain Industrial Revenue Bonds must be held in escrow until related project spending occurs and are classified as noncurrent assets in the balance sheet.
Capital expenditures are detailed in the table below.
| Nine Months Ended 30 June 2009 | 2008 | |
|---|---|---|
| Additions to plant and equipment | $899.3 | $791.4 |
| Acquisitions, less cash acquired | 29.8 | 2.0 |
| Investment in and advances to unconsolidated affiliates | 1.1 | 1.8 |
| Total Capital Expenditures on a GAAP basis | $930.2 | $795.2 |
| Capital lease expenditures under EITF No. 01-08 (a) | 111.6 | 153.1 |
| Capital Expenditures on a Non-GAAP basis | $1,041.8 | $948.3 |
(a) The Company utilizes a non-GAAP measure in the computation of capital expenditures and includes spending associated with facilities accounted for as capital leases. Certain facilities that are built to service a specific customer are accounted for as capital leases in accordance with EITF No. 01-08, “Determining Whether an Arrangement Contains a Lease,” and such spending is reflected as a use of cash within cash provided by operating activities. The presentation of this non-GAAP measure is intended to enhance the usefulness of information by providing a measure which the Company’s management uses internally to evaluate and manage the Company’s capital expenditures.
Financing Activities
Cash used for financing activities decreased $428.5. During the first nine months of 2009, the Company did not purchase any of its outstanding shares, as compared to the prior year which included share repurchases of $560.2. This was partially offset primarily by lower proceeds from stock option exercises of $66.0 and the associated excess tax benefits from share-based compensation of $46.0.
Total debt at 30 June 2009 and 30 September 2008, expressed as a percentage of the sum of total debt, shareholders’ equity, and minority interest, were 45.0% and 43.4%, respectively. Total debt increased from $3,966.8 at 30 September 2008 to $4,145.2 at 30 June 2009.
The Company’s total multicurrency revolving facility, maturing in May 2011, amounted to $1,450.0 at 30 June 2009. No borrowings were outstanding under these commitments. Additional commitments totaling $313.0 are maintained by the Company’s foreign subsidiaries, of which $307.1 were utilized at 30 June 2009.
On 20 September 2007, the Board of Directors authorized the repurchase of up to $1,000 of the Company’s outstanding common stock. During the nine months ended 30 June 2009, the Company did not purchase any shares under this authorization. At 30 June 2009, $649.2 in share repurchase authorization remained.
CONTRACTUAL OBLIGATIONS
The Company is obligated to make future payments under various contracts such as debt agreements, lease agreements, unconditional purchase obligations, and other long-term obligations.
There have been no material changes to contractual obligations as reflected in the Management’s Discussion and Analysis in the Company’s 2008 annual report on Form 10-K.
COMMITMENTS AND CONTINGENCIES
Refer to Note 19 to the Consolidated Financial Statements in the Company’s 2008 annual report on Form 10-K and Note 12 in this quarterly filing.
OFF-BALANCE SHEET ARRANGEMENTS
There have been no material changes to off-balance sheet arrangements as reflected in the Management’s Discussion and Analysis in the Company’s 2008 annual report on Form 10-K. The Company’s off-balance sheet arrangements are not reasonably likely to have a material impact on financial condition, changes in financial condition, results of operations, or liquidity.
RELATED PARTY TRANSACTIONS
The Company’s principal related parties are equity affiliates operating primarily in the industrial gas business. The Company did not engage in any material transactions involving related parties that included terms or other aspects that differ from those which would be negotiated at arm’s length with clearly independent parties.
MARKET RISKS AND SENSITIVITY ANALYSIS
Information on the Company’s utilization of financial instruments and an analysis of the sensitivity of these instruments to selected changes in market rates and prices is included in the Company’s 2008 annual report on Form 10-K.
There were no material changes to market risk sensitivities for interest rate risk on fixed debt, foreign currency exchange rate risk, or commodity price risk since 30 September 2008.
The net financial instrument position increased from a liability of $3,629 at 30 September 2008 to a liability of $3,917 at 30 June 2009, primarily due to the issuance of new long-term debt, the reclassification of commercial paper to long-term debt, and the impact of lower interest rates on the market value of long-term debt.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management’s Discussion and Analysis of the Company’s financial condition and results of operations is based on the consolidated financial statements and accompanying notes that have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The significant accounting policies of the Company are described in Note 1 to the Consolidated Financial Statements and the critical accounting policies and estimates are described in the Management’s Discussion and Analysis included in the 2008 annual report on Form 10-K. Information concerning the Company’s implementation and impact of new accounting standards issued by the Financial Accounting Standards Board (FASB) is included in Note 2 to the Consolidated Financial Statements. There have been no changes in accounting policy in the current period that had a material impact on the Company’s financial condition, change in financial condition, liquidity or results of operations.
NEW ACCOUNTING STANDARDS
See Note 2 to the Consolidated Financial Statements for information concerning the Company’s implementation and impact of new accounting standards.
FORWARD-LOOKING STATEMENTS
This Quarterly Report contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date this Report is filed regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including, without limitation, longer than anticipated delay in global economic recovery, renewed deterioration in economic and business conditions; weakening demand for the Company’s products; future financial and operating performance of major customers and industries served by the Company; inability to collect receivables from or recovery of payments made by customers in bankruptcy proceedings; unanticipated contract terminations or customer cancellations or postponement of projects and sales; asset impairments due to economic conditions or specific product or customer events; costs associated with future restructuring actions which are not currently planned or anticipated; the impact of competitive products and pricing; interruption in ordinary sources of supply of raw materials; the ability to recover unanticipated increased energy and raw material costs from customers; costs and outcomes of litigation or regulatory activities; consequences of acts of war or terrorism impacting the United States’ and other markets; the effects of a pandemic or epidemic or a natural disaster; charges related to current portfolio management and cost reduction actions; the success of implementing cost reduction programs and achieving anticipated acquisition synergies; the timing, impact, and other uncertainties of future acquisitions or divestitures; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the continued availability of capital funding sources in all of the Company’s foreign operations; the impact of new or changed environmental, healthcare, tax or other legislation and regulations in jurisdictions in which the Company and its affiliates operate; the impact of new or changed financial accounting standards; the timing and rate at which tax credits can be utilized; and other risk factors described in Part II below and in the Company’s Form 10-K for its year ended 30 September 2008 and Form 10-Q for the quarter ended 31 December 2008. The Company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this document to reflect any change in the Company’s assumptions, beliefs or expectations or any change in events, conditions, or circumstances upon which any such forward-looking statements are based.
Market risk
As filed, 161 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Refer to the Market Risks and Sensitivity Analysis on page 40 of Item 2 in Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Controls and procedures
As filed, 1,271 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We maintain a comprehensive set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) designed to ensure that information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported accurately and within the time periods specified in the SEC’s rules and forms. As of 30 June 2009 (the Evaluation Date), an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, the design and operation of these disclosure controls and procedures were effective to provide reasonable assurance of the achievement of the objectives described above.
During the quarter that ended on the Evaluation Date, there was no change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2009-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2009-04-01 to 2009-06-30 | $1.98bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2008-10-01 to 2009-06-30 | $6.13bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2009-04-01 to 2009-06-30 | $1.43bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2008-10-01 to 2009-06-30 | $4.50bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2009-04-01 to 2009-06-30 | $24.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2008-10-01 to 2009-06-30 | $86.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2009-04-01 to 2009-06-30 | $232.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2008-10-01 to 2009-06-30 | $709.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2009-04-01 to 2009-06-30 | $143.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2008-10-01 to 2009-06-30 | $518.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2009-04-01 to 2009-06-30 | $27.5m | us-gaap:InterestExpense |
| Interest expense | 9 months2008-10-01 to 2009-06-30 | $94.0m | us-gaap:InterestExpense |
| Income tax | 3 months2009-04-01 to 2009-06-30 | $25.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2008-10-01 to 2009-06-30 | $99.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2009-04-01 to 2009-06-30 | $113.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2008-10-01 to 2009-06-30 | $387.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2009-04-01 to 2009-06-30 | $0.53 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2008-10-01 to 2009-06-30 | $1.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2009-04-01 to 2009-06-30 | $0.54 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2008-10-01 to 2009-06-30 | $1.85 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2009-04-01 to 2009-06-30 | 214,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2008-10-01 to 2009-06-30 | 212,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2008-10-01 to 2009-06-30 | $857.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2008-10-01 to 2009-06-30 | $899.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2008-10-01 to 2009-06-30 | $278.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2008-10-01 to 2009-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2009-06-30 | $70.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2009-06-30 | $2.57bn | us-gaap:AssetsCurrent |
| Total assets | At period end2009-06-30 | $12.24bn | us-gaap:Assets |
| Current liabilities | At period end2009-06-30 | $1.79bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2009-06-30 | $7.18bn | us-gaap:Liabilities |
| Long-term debt | At period end2009-06-30 | $3.76bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2009-06-30 | $3.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2009-06-30 | $385.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2009-06-30 | $4.93bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950123-09-025125. Last ingested by Listed: Nov 5, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.